Atomistry » Chlorine » PDB 5i1t-5ibn » 5ia1
Atomistry »
  Chlorine »
    PDB 5i1t-5ibn »
      5ia1 »

Chlorine in PDB 5ia1: Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with MLN8054

Enzymatic activity of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with MLN8054

All present enzymatic activity of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with MLN8054:
2.7.10.1;

Protein crystallography data

The structure of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with MLN8054, PDB code: 5ia1 was solved by D.Kudlinzki, V.L.Linhard, S.L.Gande, S.Sreeramulu, K.Saxena, S.Heinzlmeir, G.Medard, B.Kuester, H.Schwalbe, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 36.26 / 2.04
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 32.714, 106.741, 40.729, 90.00, 108.79, 90.00
R / Rfree (%) 18.1 / 22.3

Other elements in 5ia1:

The structure of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with MLN8054 also contains other interesting chemical elements:

Fluorine (F) 2 atoms

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with MLN8054 (pdb code 5ia1). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with MLN8054, PDB code: 5ia1:

Chlorine binding site 1 out of 1 in 5ia1

Go back to Chlorine Binding Sites List in 5ia1
Chlorine binding site 1 out of 1 in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with MLN8054


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with MLN8054 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1001

b:54.8
occ:1.00
 CL1 A:ZZL1001 0.0 54.8 1.0
C26 A:ZZL1001 1.8 43.1 1.0
C28 A:ZZL1001 2.7 42.0 1.0
C25 A:ZZL1001 2.7 38.0 1.0
CA A:GLY620 3.6 47.1 1.0
N A:GLY622 3.7 57.5 1.0
N A:ALA621 3.8 57.1 1.0
C A:GLY620 4.0 51.8 1.0
CA A:GLY622 4.0 60.7 1.0
C29 A:ZZL1001 4.0 40.6 1.0
C24 A:ZZL1001 4.0 39.5 1.0
CG2 A:VAL627 4.1 41.9 1.0
CB A:VAL627 4.3 41.4 1.0
C30 A:ZZL1001 4.5 40.8 1.0
C A:ALA621 4.6 59.5 1.0
N A:GLY620 4.7 43.5 1.0
O A:ILE619 4.8 41.9 1.0
CA A:ALA621 4.8 59.4 1.0
CG1 A:VAL627 4.8 39.5 1.0
O A:GLY620 4.9 51.4 1.0

Reference:

S.Heinzlmeir, D.Kudlinzki, S.Sreeramulu, S.Klaeger, S.L.Gande, V.Linhard, M.Wilhelm, H.Qiao, D.Helm, B.Ruprecht, K.Saxena, G.Medard, H.Schwalbe, B.Kuster. Chemical Proteomics and Structural Biology Define EPHA2 Inhibition By Clinical Kinase Drugs. Acs Chem. Biol. V. 11 3400 2016.
ISSN: ESSN 1554-8937
PubMed: 27768280
DOI: 10.1021/ACSCHEMBIO.6B00709
Page generated: Fri Jul 26 09:14:03 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy